The 3 analysts offering 1 year price forecasts for BIOLINE RX have a max estimate of 49.9 and a min estimate of 16.1.
Analyst rating
Based on 2 analysts giving stock ratings to BIOLINE RX in the past 3 months.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong buy
1
Buy
0
Hold
1
Sell
0
Strong sell
0
EPS
Forecast
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
−0.08
−0.06
−0.04
−0.02
0.00
Reported
Estimate
Currency: ILS
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Reported
−0.07
−0.08
−0.05
0.00
0.00
0.00
−0.01
—
—
—
—
Estimate
−0.04
−0.05
−0.05
−0.07
−0.02
−0.01
0.00
−0.01
0.00
−0.01
−0.01
Surprise
−75.59%
−42.15%
+13.64%
+100.00%
+100.00%
+100.00%
−98.14%
—
—
—
—
Revenue
Forecast
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
0.00
11.00 M
22.00 M
33.00 M
44.00 M
Reported
Estimate
Currency: ILS
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Reported
0.00
0.00
17.43 M
25.51 M
20.38 M
18.45 M
42.81 M
—
—
—
—
Estimate
0.00
0.00
544.64 K
1.26 M
14.85 M
19.74 M
28.12 M
5.52 M
6.77 M
7.60 M
8.36 M
Surprise
—
—
+3,100.00%
+1,929.41%
+37.23%
−6.57%
+52.22%
—
—
—
—
Be warned
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
BLRX EPS for the last quarter is −0.01 ILA despite the estimation of −0.00 ILA. In the next quarter EPS is expected to reach −0.01 ILA. Track more of BIOLINE RX financials and stay on top of what is up with the company.
In the next quarter BIOLINE RX revenue is expected to reach 5.52 M ILA. Check out BIOLINE RX revenue and earnings and make informed decisions.
According to analysts, BLRX price target is 30.31 ILA with a max estimate of 49.93 ILA and a min estimate of 16.15 ILA. Check if this forecast comes true in a year, meanwhile watch BIOLINE RX stock price chart and keep track of the current situation with BLRX news and stock market news.